Genitourinary Cancers | Tumor

Olivia Munn Has Hysterectomy After Breast Cancer, Michael McDonald’s Lesson from Wife’s Cancer and More

May 17th 2024, 3:00pm

Article

From Olivia Munn opening up about undergoing a hysterectomy and egg retrieval to Michael McDonald’s learned lesson after his wife’s cancer, here’s what’s going on in the oncology space this week.

Erleada, ADT ‘One-Two Punch’ in Prostate Cancer Treatment

May 16th 2024, 7:00pm

Article

The postsurgical combination of androgen deprivation therapy and Erleada has shown promising results in prostate cancer.

Most BCG-Unresponsive Bladder Cancer Responds to TAR-200 Treatment

May 8th 2024, 7:00pm

Article

A novel delivery system of gemcitabine called TAR-200 led to promising responses in certain patients with non-muscle-invasive bladder cancer.

FDA to Review Injectable Opdivo for All Approved Indications

May 8th 2024, 3:00pm

Article

The Food and Drug Administration granted a Biologics License Application for subcutaneous Opdivo for potential approval.

Initial Quality of Life Decreases After Radiation in Prostate Cancer

May 6th 2024, 7:00pm

Article

Treatment with a certain radiation therapy worsens quality of life in patients with prostate cancer. An expert explains ways to mitigate side effects.

Embracing a New Way of Life After Cancer

May 2nd 2024, 5:00pm

Article

After recovering from testicular cancer, I feel as though I've earned a second life where I face my fears head-on.

Urine Test Decreases Cystoscopies in Patients With Bladder Cancer

April 30th 2024, 7:00pm

Article

A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer.

Enhertu Marks First Therapy Approved Across HER2-Positive Solid Tumors

April 24th 2024, 1:00pm

Article

Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.

FDA Approves Anktiva Plus BCG for Certain Bladder Cancer Subset

April 22nd 2024, 11:48pm

Article

A treatment combination of Anktiva and Bacillus Calmette-Guérin was approved by the FDA for certain patients with non-muscle-invasive bladder cancer.

Padcev-Keytruda Combo Nearly Doubles Survival Time in Bladder Cancer

April 19th 2024, 9:00pm

Article

The survival benefit observed with Padcev plus Keytruda was “unlike anything we’d seen before” for advanced bladder cancer, according to an expert.